Researchers from Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center (BMC) reviewed cancer ...
Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...
Cancer researchers analyzed records from 160,000 patients to find that germs may influence the potential for a relatively ...
Beyond avoiding cavities and gum disease, a new study finds good oral hygiene also protects against head and neck cancer.
In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens ...
Those with poor oral health are more vulnerable than those with healthier mouths to cancers of the throat and head, a recent ...
In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the ...
Cheers to … sobriety? Andrews shares that she’s a teetotaler in the name of total body betterment, “I do not consume any alcohol. All types of alcohol — including red wine — are going to increase your ...
Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.
Merck's Keytruda (pembrolizumab) met primary endpoint of event-free survival (EFS) in Phase 3 trial for newly diagnosed head ...
Discover the potential link between the oral microbiome and the development of head and neck squamous cell cancer ...
The KEYNOTE-689 study evaluating pembrolizumab in this patient population met its primary end point of event-free survival.